2 results
Approved WMOCompleted
To assess the benefits and harms of SUP with PPI in adult, critically ill patients in the ICU.
Approved WMORecruiting
To evaluate whether a faecal calprotectin guided strategy of anti-TNF dosing interval lengthening is non-inferior in maintaining remission in patients with IBD compared with an unchanged dosing interval.